Bringing the fundamentals into focus…
Back to Royalty Pharma plc
How Royalty Pharma plc stacks up
RPRX · against 1,335 other Healthcare companies
Profitability
80/ 100
Near the top of its peers.
Ranked #262 of 1,336 · scores higher than 80% of peers
Bars: peers in each 10-point band of the profitability score133 peers with a profitability score of 80–89, including RPRX · Click a bar to see the companies
Why profitability scores 80?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin and return on assets, which are stronger than most Healthcare peers.
- Return on invested capital is close to the peer norm. Return on invested capital: 6.7% vs peer median 4.7%
- a higher return on assets: stronger than 67% of peers. Return on assets: 4.1% vs peer median 1.7%
- a wider operating margin: stronger than 99% of peers. Operating margin: 59.6% vs peer median 7.1%
Metric by metric
Position: dot = RPRX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RPRX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 1,226 reported | 6.7% | 4.7% | 57% | 33% | |
| Operating marginHigher is better · 1,251 reported | 59.6% | 7.1% | 99% | 33% | |
| Return on assetsHigher is better · 1,315 reported | 4.1% | 1.7% | 67% | 33% | |
| Return on equityHigher is better · 1,252 reported | 14.0% | 3.2% | 80% | Context only | |
| Gross marginHigher is better · 1,394 reported | 95.8% | 45.9% | 96% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around RPRX| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 1 | 174.8B INR (≈$2.1B) | 100 | 73 | |
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 5 | 12.3B CNY (≈$1.7B) | 99 | 85 | |
| 262 | 3.5B USD | 80 | 75 | |
| 262 | 7.0B USD | 80 | 63 | |
| 262 | 5.1B USD | 80 | 54 | |
| 262 | 2.6B AUD (≈$1.7B) | 80 | 62 | |
| 262 | 38.4B USD | 80 | 50 | |
| 262 | 48.9B USD | 80 | 54 | |
| 275 | 5.2B CNY (≈$725M) | 79 | 66 | |
| 275 | 3.53T JPY (≈$24.0B) | 79 | 68 | |
| 275 | 31.3B CNY (≈$4.4B) | 79 | 65 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score